Linked Life Data

17882656

Source:http://linkedlifedata.com/resource/pubmed/id/17882656

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-9-20
pubmed:abstractText
A Phase I investigation of docetaxel, carboplatin, and capecitabine at our institution demonstrated the safety and tolerability of this regimen in patients with metastatic esophagogastric cancer. The objectives of this Phase II study were to determine the response rate, toxicity, and survival for patients with metastatic esophagogastric cancer treated with this regimen.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0735-7907
pubmed:author
pubmed:issnType
Print
pubmed:volume
25
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
445-8
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Docetaxel, capecitabine and carboplatin in metastatic esophagogastric cancer: a phase II study.
pubmed:affiliation
The Brown University Oncology Group, Providence, Rhode Island 02906, USA.
pubmed:publicationType
Journal Article, Clinical Trial, Phase II